Communiqués Harvard Bioscience, Inc.

Actions

HBIO

US4169062043

Equipement et technologie médicale avancés

Marché Fermé - Nasdaq 22:00:00 26/08/2026			Varia. 5j.	Varia. 1 janv.
7,650 ^USD	+0,92 %		+8,05 %	+14,38 %

11/08	Harvard Bioscience, Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
11/08	Transcript : Harvard Bioscience, Inc., Q2 2026 Earnings Call, Aug 11, 2026

Communiqués

11/08	Harvard Bioscience: Q2 Earnings Snapshot	AQ
11/08	Harvard Bioscience Announces Second Quarter 2026 Financial Results	AQ
28/07	Harvard Bioscience Schedules Second Quarter 2026 Earnings Conference Call for August 11, 2026 at 8:00 AM ET	AQ
12/05	Harvard Bioscience : Q1 2026 Harvard Bioscience, Inc. Earnings Conference Call	PU
12/05	Harvard Bioscience: Q1 Earnings Snapshot	AQ
12/05	Harvard Bioscience Announces First Quarter 2026 Financial Results	AQ
07/05	Harvard Bioscience to Participate in Upcoming Investor Conferences	AQ
28/04	Harvard Bioscience Schedules First Quarter 2026 Earnings Conference Call for May 12, 2026 at 8:00 AM ET	AQ
12/03	Harvard Bioscience: Q4 Earnings Snapshot	AQ
12/03	Harvard Bioscience : Q4 2025 Harvard Bioscience, Inc. Earnings Conference Call	PU
12/03	Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results	GL
06/03	Harvard Bioscience Announces Reverse Stock Split	GL
03/03	Harvard Bioscience to Participate in KeyBanc’s Virtual Healthcare Forum	GL
26/02	Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET	GL
10/02	Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas	GL
29/01	Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth	GL
17/12	Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package	GL
17/12	Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package	AQ
06/11	Harvard Bioscience: Q3 Earnings Snapshot	AQ
06/11	Harvard Bioscience Announces Third Quarter 2025 Financial Results	GL
30/10/25	Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET	GL
16/09/25	Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States	GL
09/09/25	Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors	GL
11/08/25	Harvard Bioscience: Q2 Earnings Snapshot	AQ
11/08/25	Harvard Bioscience : Q2 2025 Harvard Bioscience, Inc. Earnings Conference Call	PU